[IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis]
- PMID: 14963598
- DOI: 10.1590/s0104-42302003000400037
[IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis]
Abstract
Purpose: To determine the levels of IgA, IgE, IgG and subclasses (IgG1, IgG4) antibodies specific to C. albicans in serum and vaginal washes from women with or without vulvovaginal candidiasis in order to evaluate the role of these antibodies in the immunopathogenesis of the disease.
Methods: Thirty women with clinical symptoms of vulvovaginal candidiasis (15 positive vaginal culture to C. albicans, 11 negative culture and 4 positive culture to non-C. albicans) and 12 asymptomatic control women were selected. Serum and vaginal wash samples were obtained for the detection of anti-C. albicans antibodies by ELISA.
Results: Symptomatic patients with positive culture showed significantly higher levels of specific IgA in vaginal washes and lower in serum than those with negative culture. Specific serum IgE levels were very low compared to vaginal IgE. High levels of total specific IgG were found in serum and vaginal washes in both groups, regardless the fungal presence or absence. Specific IgG1 and IgG4 levels were significantly higher only in vaginal washes from symptomatic patients with positive culture, with a slightly higher IgG1/IgG4 ratio, indicating that the IgG1 antibody response may be predominantly involved in the fungal clearance.
Conclusion: Our results indicate a pronounced antibody response of IgA, IgG1 and IgG4 to C. albicans in vaginal washes in symptomatic patients with positive culture, suggesting a important role of these antibodies in the local immune response triggered by the presence of the fungus.
Similar articles
-
Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis.Gynecol Obstet Invest. 1994;37(2):110-4. doi: 10.1159/000292536. Gynecol Obstet Invest. 1994. PMID: 8150365
-
Immunoglobulin classes of human serum antibodies in vaginal candidiasis.Mycopathologia. 1978 Aug 10;63(3):173-5. doi: 10.1007/BF00490933. Mycopathologia. 1978. PMID: 357978
-
Candida-specific antibodies during experimental vaginal candidiasis in mice.Infect Immun. 2002 Oct;70(10):5790-9. doi: 10.1128/IAI.70.10.5790-5799.2002. Infect Immun. 2002. PMID: 12228309 Free PMC article.
-
Recurrent vulvovaginal candidiasis: why does it occur?Int J STD AIDS. 1999 Jul;10(7):435-9; quiz 440-1. doi: 10.1258/0956462991914429. Int J STD AIDS. 1999. PMID: 10454177 Review. No abstract available.
-
Anticandidal immunity and vaginitis: novel opportunities for immune intervention.Infect Immun. 2007 Oct;75(10):4675-86. doi: 10.1128/IAI.00083-07. Epub 2007 Jun 11. Infect Immun. 2007. PMID: 17562759 Free PMC article. Review. No abstract available.
Cited by
-
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives.J Fungi (Basel). 2020 Nov 7;6(4):267. doi: 10.3390/jof6040267. J Fungi (Basel). 2020. PMID: 33171784 Free PMC article. Review.
-
The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis.Vaccines (Basel). 2021 Oct 10;9(10):1159. doi: 10.3390/vaccines9101159. Vaccines (Basel). 2021. PMID: 34696267 Free PMC article. Review.
-
Candidiasis--do we need to fight or to tolerate the Candida fungus?Folia Microbiol (Praha). 2007;52(3):297-312. doi: 10.1007/BF02931313. Folia Microbiol (Praha). 2007. PMID: 17702470 Review.
-
Allergic vulvovaginitis: a systematic literature review.Arch Gynecol Obstet. 2022 Sep;306(3):593-622. doi: 10.1007/s00404-021-06332-z. Epub 2021 Nov 26. Arch Gynecol Obstet. 2022. PMID: 34825938
-
Candida infections of the genitourinary tract.Clin Microbiol Rev. 2010 Apr;23(2):253-73. doi: 10.1128/CMR.00076-09. Clin Microbiol Rev. 2010. PMID: 20375352 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous